Sophie Laffont
Rennes, 35042, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
188Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study).
Journal: Cancers
Published: February 20, 2023
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: June 23, 2020
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with 188Re-SSS Lipiodol radioembolization.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 09, 2018
A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 27, 2017
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 17, 2017
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90 Y-loaded glass microsphere radioembolization.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 29, 2016
Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolization.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 31, 2015
Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 12, 2015
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 14, 2015
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 17, 2013
Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 04, 2012
Reduction of β-radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment.
Journal: Nuclear medicine communications
Published: November 30, 2011
Last Updated: 09/26/2026